Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs ImmunityBio Inc. Common Stock — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.32 (market cap $40.01B), while ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 3.8× ImmunityBio Inc. Common Stock's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.14% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 1 Days and ImmunityBio Inc. Common Stock for 1 Days on average.
| HLN | IBRX | |
|---|---|---|
Market Cap | $40.01B | $10.51B |
Volume | 19,985,935 | 10,445,785 |
Sector | Health | Health |
52-Week High | $11.27 | $11.55 |
52-Week Low | $8.70 | $1.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $49.79B | $10.97B |
Dividend Yield | 2.14% | — |
Trailing returns across standard periods
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →